Urine test shows prostate cancer risk, U-M study finds

Test for gene fusion can assist in the early detection of prostate cancer

2011-08-04

(Press-News.org) ANN ARBOR, Mich. — A new urine test can help aid early detection of and treatment decisions about prostate cancer, a study from the University of Michigan Comprehensive Cancer Center and the Michigan Center for Translational Pathology finds.

The test supplements an elevated prostate specific antigen, or PSA, screening result, and could help some men delay or avoid a needle biopsy while pointing out men at highest risk for clinically significant prostate cancer.

The test looks for a genetic anomaly that occurs in about half of all prostate cancers, an instance of two genes changing places and fusing together. This gene fusion, TMPRSS2:ERG, is believed to cause prostate cancer. Studies in prostate tissues show that the gene fusion almost always indicates cancer. But because the gene fusion is present only half the time, the researchers also included another marker, PCA3. The combination was more predictive of cancer than either marker alone.

Results of the study appear Aug. 3 in Science Translational Medicine.

"Testing for TMPRSS2:ERG and PCA3 significantly improves the ability to predict whether a man has prostate cancer," says lead author Scott Tomlins, M.D., Ph.D., a pathology resident at the U-M Health System. "We think this is going to be a tool to help men with elevated PSA decide if they need a biopsy or if they can delay having a biopsy and follow their PSA and urine TMPRSS2:ERG and PCA3."

The researchers looked at urine samples from 1,312 men at three academic medical centers and seven community-based hospitals. The men all had elevated PSA levels and had gone on to receive either a biopsy or prostatectomy, surgery to remove their prostates. The researchers evaluated the urine samples for TMPRSS2:ERG and PCA3 and stratified patients into low, intermediate and high scores, indicating their risk of cancer. They then compared this to biopsy results.

Biopsies indicated cancer in 21 percent of men from the low-score group, 43 percent in the intermediate group and 69 percent in the high group. Further, the urine test scores correlated with how aggressive the cancer was, based on tumor size and Gleason score, a measure of how abnormal the cells look. Only 7 percent of men in the low-score group had an aggressive tumor while 40 percent of those in the high-score group did.

"Many more men have elevated PSA than actually have cancer but it can be difficult to determine this without biopsy. This test will help in this regard. The hope is that this test could be an intermediate step before getting a biopsy," says senior study author Arul Chinnaiyan, M.D., Ph.D., director of the Michigan Center for Translational Pathology and S.P. Hicks Professor of Pathology at the U-M Medical School. Chinnaiyan is also a Howard Hughes Medical Institute researcher.

Prostate biopsies are done with a needle in an office setting, but they do pose some discomfort and risk to the patient. In addition, a biopsy can offer an incomplete picture since urologists are testing the prostate as a whole, rather than a specific lesion.

The combined TMPRSS2:ERG and PCA3 test is not yet available as a prostate cancer screening tool. The Michigan Center for Translational Pathology is working with Gen-Probe Inc., which has licensed the technology, and hopes to offer it to U-M patients within the year. U-M currently offers PCA3 screening alone as follow-up to elevated PSA. Men with questions about prostate cancer screening should speak to their doctors or call the U-M Cancer AnswerLine at 800-865-1125.

INFORMATION:

Prostate cancer statistics: 217,730 Americans will be diagnosed with prostate cancer this year and 32,050 will die from the disease, according to the American Cancer Society

Additional authors: From U-M: Javed Siddiqui, Robert J. Lonigro, Laurie Sefton-Miller, Radhika Varambally, Bo Han, David Wood, Lei Wang, Daniel Rhodes, Brent Hollenbeck, Stephanie Meyers, Nallasivam Palanisamy, John T. Wei; from Gen-Probe: Sheila M.J. Aubin, Siobhan Miick, Sarah Williamsen, Petrea Hodge, Jessica Meinke, Amy Blase, Yvonne Penabella, John R. Day, Harry Rittenhouse, Jack Groskopf; from Harvard Medical School: Martin G. Sanda; from Weill Cornell Medical College: Mark A. Rubin; from University of California San Diego Medical Center: Kyoko Sakamoto, Jonathan L. Silberstein; from Universite Laval, Quebec: Yves Fradet; from Dianon Systems Inc.: James B. Amberson

Funding: Gen-Probe Inc., the Early Detection Research Network, National Institutes of Health, Prostate Cancer Foundation, Burroughs Wellcome Fund, Doris Duke Foundation, Howard Hughes Medical Institute

Disclosure: The University of Michigan and Brigham and Women's Hospital have been issued a patent on the detection of ETS gene fusions in prostate cancer, on which Tomlins, Rubin, Rhodes and Chinnaiyan are listed as co-inventors. The diagnostic field of use has been licensed to Gen-Probe. Chinnaiyan has served as a consultant to Gen-Probe. Fradet is co-founder of Diagnocure, which licensed diagnostic rights to the PCA3 gene to Gen-Probe.

Reference: Science Translational Medicine, Vol. 3, No. 94, Aug. 3, 2011

Resources:
U-M Cancer AnswerLine, 800-865-1125
U-M Comprehensive Cancer Center, www.mcancer.org
Clinical trials at U-M, www.UMClinicalStudies.org

[Attachments] See images for this press release:

ELSE PRESS RELEASES FROM THIS DATE:

6 million years of savanna

2011-08-04

SALT LAKE CITY, Aug. 3, 2011 – University of Utah scientists used chemical isotopes in ancient soil to measure prehistoric tree cover – in effect, shade – and found that grassy, tree-dotted savannas prevailed at most East African sites where human ancestors and their ape relatives evolved during the past 6 million years. "We've been able to quantify how much shade was available in the geological past," says geochemist Thure Cerling, senior author of a study of the new method in the Thursday, Aug. 4, 2011 issue of the journal Nature. "And it shows there have been open ...

What steers vampires to blood

2011-08-04

Scientists have known for years that when vampire bats tear through an animal's skin with their razor-sharp teeth, their noses guide them to the best spots – where a precise bite will strike a vein and spill forth nourishing blood. But nobody knew exactly how bats knew where to bite. By investigating wild vampire bats in South America, researchers at the University of California, San Francisco and Instituto Venezolano de Investigaciones Científicas in Caracas, Venezuela have discovered their secret: a sensitive, heat-detecting molecule covering nerve endings on their ...

Unconventional hunt for new cancer targets leads to a powerful drug candidate for leukemia

2011-08-04

Cold Spring Harbor, N.Y. – Scientists at Cold Spring Harbor Laboratory (CSHL) and five other institutions have used an unconventional approach to cancer drug discovery to identify a new potential treatment for acute myeloid leukemia (AML). As reported in Nature online on August 3, the scientists have pinpointed a protein called Brd4 as a novel drug target for AML, an aggressive blood cancer that is currently incurable in 70% of patients. Using a drug compound that inhibits the activity of Brd4, the scientists were able to suppress the disease in experimental models. "The ...

Natural killer cells participate in immune response against HIV

2011-08-04

A new study shows for the first time that natural killer (NK) cells, which are part of the body's first-line defence against infection, can contribute to the immune response against HIV. In an article in the August 4 issue of Nature, a research team based at the Ragon Institute of MGH, MIT and Harvard reports that the HIV strains infecting individuals with particular receptor molecules on their NK cells had variant forms of key viral proteins, implying that the virus had mutated to avoid NK cell activity. "This study suggests for the first time that NK cells can impose ...

VISTA finds 96 star clusters hidden behind dust

2011-08-04

This result comes just one year after the start of the VISTA Variables in the Via Lactea programme (VVV) [1], one of the six public surveys on the new telescope. The results will appear in the journal Astronomy & Astrophysics. "This discovery highlights the potential of VISTA and the VVV survey for finding star clusters, especially those hiding in dusty star-forming regions in the Milky Way's disc. VVV goes much deeper than other surveys," says Jura Borissova, lead author of the study. The majority of stars with more than half of the mass of our Sun form in groups, ...

Calcifying microalgae are witnesses of increasing ocean acidification

2011-08-04

Bremerhaven, 1 August 2011. For the first time researchers have examined on a global scale how calcified algae in their natural habitat react to increasing acidification due to higher marine uptake of carbon dioxide. In the current issue of the magazine Nature they explain that Coccolithophores, a certain group of algae, form thinner calcite skeletons when the pH value in the ocean drops. In marine ecosystems, changes in the degree of calcification are much more pronounced than presumed to date based on laboratory tests. These changes have an impact on the global carbon ...

'Big splat' may explain the moon's mountainous far side

2011-08-04

SANTA CRUZ, CA--The mountainous region on the far side of the moon, known as the lunar farside highlands, may be the solid remains of a collision with a smaller companion moon, according to a new study by planetary scientists at the University of California, Santa Cruz. The striking differences between the near and far sides of the moon have been a longstanding puzzle. The near side is relatively low and flat, while the topography of the far side is high and mountainous, with a much thicker crust. The new study, published in the August 4 issue of Nature, builds on the ...

NOAA study: Slowing climate change by targeting gases other than carbon dioxide

2011-08-04

Carbon dioxide remains the undisputed king of recent climate change, but other greenhouse gases measurably contribute to the problem. A new study, conducted by NOAA scientists and published online today in Nature, shows that cutting emissions of those other gases could slow changes in climate that are expected in the future. Discussions with colleagues around the time of the 2009 United Nations' climate conference in Copenhagen inspired three NOAA scientists – Stephen Montzka, Ed Dlugokencky and James Butler of NOAA's Earth System Research Laboratory in Boulder, Colo. ...

Italian academia is a family business, statistical analysis reveals

2011-08-04

Unusually high clustering of last names within Italian academic institutions and disciplines indicates widespread nepotism in the country's schools, according to a new computational analysis. By comparing the frequency of last names among more than 61,000 professors in medicine, engineering, law, and other fields, University of Chicago researcher Stefano Allesina found the pattern to be incompatible with unbiased, equal opportunity hiring. The analysis, published online in the journal PLoS ONE, refutes the notion that recently publicized cases of academic nepotism in ...

Stanford study identifies potential anti-cancer therapy that starves cancer cells of glucose

2011-08-04

STANFORD, Calif. — Stanford University School of Medicine researchers have identified a compound that attacks the Achilles' heel of certain cancer cells by depriving them of their energy source, the sugar glucose. Cancer chemotherapy can be a rough ride, in part because most of these drugs don't distinguish between what's cancerous and what's not. The chemicals attack all rapidly dividing cells, from cancer cells, to blood cells and the cells that make hair. However, drugs that target a biological phenomenon only found in cancer cells, such as the compound recently discovered ...

Urine test shows prostate cancer risk, U-M study finds

ELSE PRESS RELEASES FROM THIS DATE:

LAST 30 PRESS RELEASES: